2020
DOI: 10.1016/j.jad.2020.05.149
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 inpatients with psychiatric disorders: Real-world clinical recommendations from an expert team in consultation-liaison psychiatry

Abstract: Highlights COVID-19 patients with psychiatric disorders should be managed on a personalized basis. Risks of pharmacological interaction are not absolute and should be contextualized. Essential psychopharmacological ongoing treatments should be maintained. Most psychotropic drugs should be reduced 25–50% if given with lopinavir/ritonavir. Dose titration should be progressive and with ECG monitoring if cardiotoxic risk.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
57
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 56 publications
(59 citation statements)
references
References 15 publications
1
57
0
1
Order By: Relevance
“…The general public are extremely vulnerable to symptoms of depression during the COVID-19 pandemic. People with mental symptoms of depression should be identified and managed in a timely manner to improve their psychological health status [ 65 ].…”
Section: Discussionmentioning
confidence: 99%
“…The general public are extremely vulnerable to symptoms of depression during the COVID-19 pandemic. People with mental symptoms of depression should be identified and managed in a timely manner to improve their psychological health status [ 65 ].…”
Section: Discussionmentioning
confidence: 99%
“…Mental health support must be integrated in the public health response during COVID-19 pandemic, in particular among populations at higher risk for mental health consequences, such as first-line healthcare professionals. Even more, people with pre-existing mental health disorders are particularly vulnerable to the stressful situations derived from the pandemic outbreak and the confinement situation, which may result in relapses or worsening of psychiatric pre-existing conditions leading to hospitalization (Vieta et al, 2020;Yao et al, 2020), requiring individualized treatment (Anmella et al, 2020). These populations should not be overlooked, and mental health home hospitalization care has been proposed as an alternative to address this problem (Garriga et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…51 As a result of the complexity of real-world clinical scenarios and the lack of case-centred recommendations, our CLP unit has issued practical recommendations for the psychopharmacological management of the most representative case scenarios that we have identified regarding patients who were admitted to hospital with COVID-19 who had psychiatric disorders, based on existing literature and clinical experience. 52 Another matter of concern has been what to do with patients requiring a psychiatric admission but who are also infected with SARS-CoV-2 (but who do not require admission because of respiratory problems). This has led to strict control of patients who need admission for psychiatric reasons using polymerase chain reaction-based tests and admissions into either (a) 'clean' psychiatric in-patient units; (b) 'COVID-19' psychiatric units, or (c) non-psychiatric COVID-19 hospital units with the support of CLP units.…”
Section: Towards a New Psychiatry In Times Of Pandemicmentioning
confidence: 99%
“…Enfermedad por el coronavirus (COVID-19). Ministerio de Sanidad -Gobierno de España 52. Data updated on the 9 July 2020.Cumulative incidence(n cases/100,000 inhabitants) Lleida: 160.72 cases/100 000 Cumulative incidence by provinces in Spain Barcelona: 9.04 cases/100 000 Epidemiological week nº 27 (29 June -5 July 2020) Cumulative incidences by province in Spain for epidemiological week 27 (29 June to 5 July 2020).…”
mentioning
confidence: 99%